The NHS drugs bill (reportedly over £15.2 billion in 2015-16) recently came into sharp focus following news reports highlighting dramatic price increases for longstanding generic drugs. Examples frequently cited include the anti-epilepsy drug phenytoin sodium, which had a reported price hike of up to 2,600 percent, and hydrocortisone tablets, the price of which reportedly increased by more than 12,000 percent.
Full article published on pages 26 - 27 in PharmaTimes Magazine - July 2017.